静脉瘤手术中的血栓预防:日常关注的问题
John F García Vélez1, Martha O Correa Posada2
1Department of Vascular Surgery, University of Antioquia, Medellín, Colombia.
在静脉静脉瘤手术中预防静脉血栓塞栓症 (VTE) 需要个性化风险评估. 目前的证据有限,需要根据患者和程序因素进行量身定制的预防.
科学领域:
- 血管外科 血管外科
- 进行血栓预防治疗.
- 基于证据的医学 基于证据的医学
背景情况:
- 静脉血栓栓塞性疾病 (VTE) 是手术患者发病率和死亡率的重要原因.
- 现有的手术血栓预防指南缺乏针对静脉瘤手术的具体证据.
- 外科医生在为这些患者开发抗血栓预防时面临不确定性.
研究的目的:
- 审查目前关于在静脉瘤手术中预防静脉瘤的文献.
- 引导临床医生选择适当的预防策略.
- 解决日常外科实践中出现的实际问题.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 对静脉瘤预防在静脉瘤手术中的证据的检查.
- 讨论各种临床情景和预防方案.
主要成果:
- 缺乏关于静脉瘤预防在静脉瘤手术中的确文献.
- 个性化风险评估至关重要.
- 预防决策应考虑患者特定的风险因素和程序细节.
结论:
- 静脉瘤手术的抗血栓预防需要个性化的方法.
- 由于缺乏确的证据,需要个性化风险分层.
- 建议根据个案评估量身定制预防的类型和持续时间.
更多相关视频
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
00:09Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
相关概念视频
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Esophageal Varices-I: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
